期刊文献+

用GM-CSF和IL-4在体外诱导高纯度CD14^+树突状细胞 被引量:5

Generation of CD14^+ Dendritic Cells in Vitro with GM-CSF and IL-4
下载PDF
导出
摘要 本研究改进传统的树突状细胞 (DC)诱导方法 ,用 GM- CSF(15 0 ng/ml)和 IL- 4 (80 0 U/ml) ,在体外经7d从健康人外周血中诱导出了大量高纯度 DC,其高表达 HL A- 、HL A- 类分子 ,共刺激分子和黏附分子 ,同时还高表达其前体单核细胞的特异性标志 CD14分子 ,显示出成熟 DC的特征。这些 CD14 + DC能强烈诱导同种异体淋巴细胞的增埴 ,其内吞能力在第 3天达最高 ,之后明显下降。此结果丰富了 DC的类型 ,并为 CD14 + This study was conducted to get high quality and sufficient numbers of mature dendritic cells from healthy donor peripheral blood. The experiment began on culturing of plastic adherent monocytes isolated from healthy donor peripheral blood with granulocyte monocyte clony stimulating factor ( GM CSF 150ng /ml ) and interleukin 4 ( IL 4 800 U/ml ) without fresh medium feeding and cytokines for 7 days. After 7 days, CD14 + monocytes not only differentiated into high purity DC but also expressed HLA Ⅰand HLA Ⅱmolecules , costimulating molecules , adherent molecules and its progenitor marker CD14 molecule highly.These cells displayed all phenotypic and morphologic characteristics of mature dendritic cells and were most potent stimulatory cells in allogeneic mixed leukocyte reactions. The endocytosis ability of these DCs peaked at the third day in culture and decreased remarkably afterwards.These results provide evidence for the first time that CD14 + monocytes differentiated in vitro from peripheral blood monocytes exhibit dendritic cells characteristics and still express its progenitor marker CD14 molecules highly .The results of this experiments may facilitate further studies of CD14 + DC and its clinical applications.
出处 《生物医学工程学杂志》 EI CAS CSCD 2002年第2期276-279,共4页 Journal of Biomedical Engineering
关键词 GM-CSF IL-4 体外诱导 高纯度CD14^+树突状细胞 Dendritic cell Monocyte Granulocyte monocyte clony stimulating factor Interleukin 4 CD14 molecule
  • 相关文献

参考文献7

  • 1Kain M.The NF- B activation pathway : its regulation and role in inflammation and cell survival[].Scientific American.1998
  • 2Liang ji -zhou,Tedder TF.CD14 + blood monocytes can differentiate into functionally mature CD83 + dendritic cells[].Proceedings of the National Academy of Sciences of the United States of America.1996
  • 3Winzler C,Rovere P,Rescigno M,et al.Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures[].The Journal of Experimental Medicine.1997
  • 4Ancuta P,Weiss L,Haeffner-Cavaillon.CD14 + CD16 + cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell -like characteristics[].European Journal of Immunology.2000
  • 5Sting G,Bergtresser PR.Dendritic cells : a major story unfold[].Immunology Today.1995
  • 6Aderem A,Ulevitch R J.Toll -like receptor in the induction of the innate immune response[].Nature.2000
  • 7Sallusto F,Cella M,Danieli C,et al.Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment : downregulation by cytokines and bacterial produces[].The Journal of Experimental Medicine.1995

同被引文献35

  • 1仲琳,张运,张梅,季哓平,陈文强,姚桂华,丁士芳,张鹏飞.兔动脉粥样硬化易损斑块模型的建立[J].基础医学与临床,2005,25(4):370-374. 被引量:30
  • 2陶忠芬,蔡永国,杨仕明,可金星,黄文琪,肖桃元,房殿春.树突状细胞扫描电镜样本制备方法[J].第三军医大学学报,2005,27(12):1299-1300. 被引量:12
  • 3缪绯,刘映峰,傅强,李志梁,李公信,吴宏超,徐琳.阿托伐他汀对外周血中树突状细胞成熟及免疫功能的影响[J].中国医科大学学报,2007,36(3):265-267. 被引量:4
  • 4[1]Hus FJ, Benike C, Fagnoni F, et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med,1996,2(1)∶52-58.
  • 5[2]Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide-tumor lysate-pulsed dendritic cells. Nat Med,1998,4(3)∶328-332.
  • 6[3]Tjoa BA, Erickson SJ, Bowes VA, et al. Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides. Prostate,1997,32(4)∶272-278.
  • 7[4]Wright-Browne V, McClain KL, Talpaz M, et al. Physiology and phathophysiology of dendritic cells.Hum Pathol,1997,28(5)∶563-579.
  • 8[7]Morse MA, Deng Y, Coleman D, et al. A PhaseⅠstudy of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. Clin Cancer Res,1999,5(6)∶1331-1338.
  • 9[8]Zhou LJ,Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Pro Natl Acad Sci USA,1996,96(3)∶2588-2592.
  • 10[10]Bell D, Young JW, Bachereau J. Dendritic cells. Adv Immunol,1999,72∶255-324.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部